D. Ziagkos

Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia ‐ A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT

J. Delgado, N. Kröger, P. Dreger, 2017, Clinical lymphoma, myeloma & leukemia.

Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion.

G. Mufti, N. Kröger, S. Iacobelli, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation*

N. Kröger, J. Sierra, M. Robin, 2019, Leukemia & lymphoma.

Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT.

H. Einsele, A. Ganser, N. Kröger, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation

N. Kröger, S. Iacobelli, A. Nagler, 2017, Haematologica.

Allogeneic : Adult Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome : A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT

H. Einsele, A. Ganser, N. Kröger, 2016 .